Production (Stage)
Diebold Nixdorf, Incorporated
DBD
$47.35
-$0.06-0.13%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.70B | 3.75B | 3.80B | 3.82B | 3.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.70B | 3.75B | 3.80B | 3.82B | 3.80B |
| Cost of Revenue | 2.76B | 2.80B | 2.86B | 2.91B | 2.91B |
| Gross Profit | 935.40M | 947.80M | 936.20M | 906.50M | 891.60M |
| SG&A Expenses | 568.90M | 568.80M | 572.80M | 558.80M | 603.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.70M | -2.00M | 1.60M | 1.60M | 1.60M |
| Total Operating Expenses | 3.42B | 3.46B | 3.53B | 3.56B | 3.60B |
| Operating Income | 281.10M | 292.00M | 272.70M | 257.90M | 196.10M |
| Income Before Tax | 57.20M | 49.80M | 59.30M | 2.27B | 1.53B |
| Income Tax Expenses | 65.20M | 64.30M | 57.30M | 108.30M | 51.50M |
| Earnings from Continuing Operations | -8.00 | -14.50 | 2.00 | 2.17K | 1.47K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.20M | -2.00M | -1.80M | -1.60M | -1.50M |
| Net Income | -10.20M | -16.50M | 200.00K | 2.16B | 1.47B |
| EBIT | 281.10M | 292.00M | 272.70M | 257.90M | 196.10M |
| EBITDA | 418.00M | 428.30M | 407.00M | 397.30M | 331.10M |
| EPS Basic | -0.27 | -0.44 | 0.01 | 38.21 | 29.35 |
| Normalized Basic EPS | 2.51 | 2.67 | 2.65 | 1.88 | 0.60 |
| EPS Diluted | -0.28 | -0.44 | 0.00 | 37.79 | 28.93 |
| Normalized Diluted EPS | 2.51 | 2.67 | 2.64 | 1.87 | 0.60 |
| Average Basic Shares Outstanding | 150.40M | 150.40M | 150.40M | 169.76M | 212.16M |
| Average Diluted Shares Outstanding | 150.50M | 150.50M | 150.50M | 170.50M | 212.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |